Search clinical trials for: Leukemic Meningitis

Total 522 results

Novartis Vaccines

Completed

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

Meningococcal Disease

Russian Federation
Assistance Publique Hopitaux De Marseille

Completed

Improving the Diagnosis of Meningitis in Emergency Rooms

Meningitis

France
Tulane University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Clinical Trial of Protein and Blood Pressure (ProBP)

Hypertension | Hypercholesterolemia
Matinas BioPharma Nanotechnologies, Inc.
University of Minnesota

Completed

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) (EnACT)

Cryptococcal Meningitis

Uganda
Chiang Mai University

Completed

Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis (TBM) in Maharaj Nakorn Chiang Mai Hospital

Tuberculous Meningitis
University of Adelaide

Completed

The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults (AMEND)

Meningococcal Infections | Neisseria Infection | Neisseria Meningitis Sepsis

Australia
M. Carmen Cabellos Minguez
Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Hospital Universitario... and other collaborators

Terminated

Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.

Seizures | Pneumococcal Meningitis

Spain
University of Chicago

Completed

In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention

Bystander Behavioral Intentions

United States
Northwell Health

Completed

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Germans Trias i Pujol Hospital

Completed

Observational Pilot Study With TachoSil as a Ventricular Sealant

Intraventricular Neoplasm

Spain
GlaxoSmithKline

Active, not recruiting

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Meningitis, Meningococcal

Germany, United States
GlaxoSmithKline
PATH; Iqvia Pty Ltd; AMP (Agence de Médecine Préventive) (in French); RAFT (Réseau... and other collaborators

Completed

A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine

Malaria | Malaria Vaccines

Ghana, Burkina Faso, Kenya
Rigshospitalet, Denmark

Completed

Host RNA Profiles to Detect Infections in Young Infants (CHILD_YIC)

Sepsis | Bacterial Infections | Fever | Bacteremia | Urinary Tract Infections | Meningitis | Infant, Newborn, Disease | Viral Infection

Denmark
Brigham and Women's Hospital

Active, not recruiting

Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in Frequent Platelets Donors (PLAT)

Preventive Immunization; Meningitis

United States
University Hospital Muenster

Completed

Microcirculation in Patients With Leukemic Hyperleukocytosis

Hyperleukocytic Syndrome

Germany
University of Rostock

Completed

Neurocognitive Impairment in Pediatric Patients With Meningoencephalitis and Sepsis-associated Encephalopathy (NCIPED)

Central Nervous System Diseases | Delirium | Brain Injuries | Critical Illness | Encephalopathy | Inflammatory Disease

Germany
Pfizer

Completed

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Meningitis | Meningococcal Vaccine | rLP2086 | Repevax | N Meningitidis Serogroup B

Germany, Finland, Poland
Mendus

Completed

Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) | Leukemic Dendritic Cell Vaccination

Netherlands
University of Southampton
University of Edinburgh; University Hospital Southampton NHS Foundation Trust

Completed

Lactamica 9: Neisseria Lactamica Inoculation in Late Pregnancy

Microbial Colonization

United Kingdom
Albert B. Sabin Vaccine Institute
ICON plc; Oklahoma Blood Institute

Completed

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Ebola Virus Disease | Marburg Virus Disease

United States
University of Utah

Completed

Hypovitaminosis D in Neurocritical Patients

Stroke | Critical Illness | Craniocerebral Trauma | Brain Neoplasms | Seizures | Meningitis | Intracranial Hemorrhages | Spinal Cord Injuries | Intracranial Aneurysm | Vitamin d Deficiency

United States
Centre Hospitalier Universitaire de Besancon

Completed

Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML) (CAR-LMC)

Chronic Myeloid Leukemia

France
D'Or Institute for Research and Education
Centers for Disease Control and Prevention; Oswaldo Cruz Foundation

Completed

Brazil ICU Encephalitis Surveillance

Encephalitis | Meningitis | Prognosis | Intensive Care Neurological Disorder | Meningitis/Encephalitis | Central Nervous System Infections and Inflammations

Brazil
Peter MacCallum Cancer Centre, Australia

Completed

Panobinostat Biological Correlates Study (VEG VCA1)

Multiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With Lymphoma

Australia
St George's, University of London
Institut Pasteur; European and Developing Countries Clinical Trials Partnership... and other collaborators

Completed

Driving Reduced AIDS-associated Meningo-encephalitis Mortality (DREAMM)

Bacterial Meningitis | AIDS-Related Opportunistic Infections | Meningo-encephalitis | Cryptococcal Meningitis | Tuberculous Meningitis | Cerebral Toxoplasmosis

Cameroon, Malawi, Tanzania
Sanofi Pasteur, a Sanofi Company

Completed

Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Pertussis | Tetanus | Diphtheria | Bacterial Meningitis | Poliomyelitis

Japan
Sanofi Pasteur, a Sanofi Company

Completed

Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Russian Federation
University of Pharmacy, Yangon

Completed

Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis

Cryptococcal Meningitis

Myanmar
University Hospital, Bordeaux

Completed

Immune Checkpoint Receptors in AML-Leukemic Initiating Cells (ICAML-LIC)

Acute Myeloid Leukemia

France
Olive View-UCLA Education & Research Institute
Centers for Disease Control and Prevention

Terminated

Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients

Meningoencephalitis | Other Syndromes Requiring Lumbar Puncture in Emergency Department

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

Meningitis | Meningococcal Infection

Russian Federation, India
London School of Hygiene and Tropical Medicine
University of Zimbabwe; Botswana Harvard AIDS Institute Partnership; Infectious...

Completed

The Lived Experience of Participants in an African Randomised Trial (LEOPARD)

HIV | Cryptococcal Meningitis

Zimbabwe, Botswana, Uganda
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Meningococcal Infections

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Meningitis, Meningococcal

Korea, Republic of, Mexico, Russian Federation, Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Finland, Germany, Hungary, Spain
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis | Invasive Meningococcal Disease

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Meningitis | Meningococcal Infection

United States
University of Oxford

Active, not recruiting

Sero-epidemiological Survey of England in 2019/2020 - COVID-19 (STORY)

COVID-19 | Diphtheria | Serogroup C Meningococcal Meningitis

United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)

United States
Stony Brook University
Karius, Inc.

Completed

Next Generation Sequencing Detection of Lyme Disease

Lyme Disease | Lyme Arthritis | Pediatric Infectious Disease | Erythema Migrans | Lyme Carditis | Lyme Disease Meningitis

United States
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Completed

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months

Meningitis, Meningococcal

China
MacroGenics
National Institute of Allergy and Infectious Diseases (NIAID)

No longer available

Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure

West Nile Virus Infection
MacroGenics
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Treatment of West Nile Virus With MGAWN1 (PARADIGM)

Encephalitis | Meningitis | West Nile Virus Infection | West Nile Fever | West Nile Neuroinvasive Disease | Acute Flaccid Paralysis

Search clinical trials for: Leukemic Meningitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations